Aurobindo Pharma Ltd
Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:	524804	NSE Symbol:	AUROPHARMA	P/E :	34.66
ISIN Demat:	INE406A01037	Div & Yield %:	0	EPS :	36.91
Book Value:	369.16	Market Cap (Rs. Cr.):	74,304.86	Face Value :	1

Date	Headline
04-Mar-26	Eugia Pharma Specialities launches Pomalidomide Capsules in US market
26-Feb-26	Eugia Pharma Specialities receives USFDA approval for Everolimus Tablets
09-Feb-26	Aurobindo Pharma board appoints directors
07-Feb-26	USFDA completes audit of Unit III of Eugia Pharma Specialities
31-Jan-26	Aurobindo Pharma to announce Quarterly Result
02-Jan-26	Auro Pharma to acquire non-oncology prescription formulations biz of Khandelwal Laboratories
30-Dec-25	Aurobindo Pharma to acquire 26% stake in Swarnaakshu Solar Power
18-Dec-25	USFDA completes inspection of APL Healthcare's Unit IV
14-Nov-25	USFDA issues EIR for Unit 1 of Apitoria Pharma
25-Oct-25	Aurobindo Pharma announces board meeting date

Company Snapshot